Products

Digital Silk is an agency focused on Creating Superior Digital Experiences for their clients. They create cutting-edge brand strategies, websites, apps and results-driven marketing campaigns for mid-size to large companies that demand results and best-in-class service. Digital Silk creates custom websites to drive higher conversions and greater SEO value to grow brands online. From start-ups to Fortune 500, we have an outstanding track record on delivering on results. Our clients include: S

Verana Health® is a digital health company revolutionizing patient care and clinical research by utilizing physician expertise and artificial intelligence to unlock the true potential of real-world data. With exclusive access to the world’s largest patient data sources in ophthalmology, urology and neurology, Verana Health is powering real-world evidence generation. Clinicians utilize these insights to improve the quality of care and quality of life for patients, and life sciences companies rely

The Mahalo Health Platform combines our complete hybrid and Decentralized Clinical Trials (DCT) suite with digital health building blocks that accelerate digital health product development. With Mahalo, researchers, founders, and executives can create digital health products and collect clinical trial evidence on a single platform. Leverage Mahalo to study new Digital Therapeutics (DTx) or add our modules to your clinical trial that help you improve adherence, reduce drop-out rates, and identify

Astera ReportMiner data extraction software enables you to liberate business data trapped in printed documents so that it can be integrated into a company’s database for operations and business intelligence applications. This saves significant human resource time and dollars, as well as freeing up resources for other more important work.

The TeraMedica Division of FUJIFILM Medical Systems U.S.A., Inc., a global healthcare informatics company, is the leading provider of vendor neutral, enterprise-wide solutions for unrestricted medical image management. The company, based in Milwaukee, WI, was founded in 2001 by leading health care information technology investors and thought leaders. It successfully deployed the first version of a cross-departmental, patient-centric clinical image archive at the Mayo Clinic in 2003. Since then,

Clinical documentation for psychologists and therapists. Clara accompanies your sessions and writes structured notes adapted to your therapeutic orientation. Clara is a clinical documentation tool designed exclusively for psychologists and psychotherapists in private practice. It accompanies therapy sessions directly in the browser — no extensions, no extra devices — and generates structured clinical notes adapted to your therapeutic orientation (CBT, systemic, psychodynamic, humanistic, and 11

Sixfold Bioscience is a preclinical-stage biotechnology company dedicated to revolutionizing RNA therapeutics through its proprietary delivery platform, Mergo®. Founded in 2017 and based in London, Sixfold focuses on developing programmable drug delivery systems that enhance the specificity and safety profiles of RNA therapies. By integrating computational biology, artificial intelligence, and advanced chemistry, Sixfold aims to overcome the critical challenge of delivering RNA therapeutics to t

Abalone Bio is a biotechnology company dedicated to developing innovative antibody-based therapeutics targeting G protein-coupled receptors (GPCRs). Their proprietary platform enables the discovery and optimization of antibodies that modulate GPCR activity, addressing a wide range of diseases with unmet medical needs. By focusing on GPCRs, which play a crucial role in various physiological processes, Abalone Bio aims to create more effective and selective treatments for conditions such as cancer

Kernal Biologics is a biotechnology company pioneering the development of mRNA-based therapeutics designed to program human cells directly within the body. By leveraging advanced AI models and proprietary lipid nanoparticle (LNP) delivery systems, Kernal Bio aims to create in vivo cell therapies that are more accessible, cost-effective, and efficient compared to traditional ex vivo methods. Their innovative approach focuses on delivering mRNA sequences that are selectively translated in target c

32 Biosciences is a biotechnology company dedicated to pioneering gut mucosal-immune science to prevent and treat gastrointestinal (GI) diseases. Focusing initially on the colon, the company addresses significant unmet medical needs by developing first-in-class therapeutics and innovative discovery platforms. Recognizing the critical role of the gastrointestinal mucosal barrier in infection risk, chronic disease, and microbiome balance, 32 Biosciences aims to restore and protect the GI mucosal-i

Algen Biotechnologies is a pioneering therapeutics company that integrates advanced CRISPR gene-modulation with artificial intelligence to revolutionize drug discovery. Originating from Nobel Laureate Jennifer Doudna's lab at UC Berkeley, Algen focuses on developing innovative medicines targeting diseases with significant unmet needs, such as cancer and chronic inflammatory conditions. By reverse-engineering disease trajectories, Algen aims to identify and modulate disease-driving RNA pathways,

Engage Bio is a biotechnology company pioneering the development of Tethosomes, a novel class of non-viral DNA medicines designed to overcome the traditional challenges of potency and toxicity in genetic therapies. By utilizing lipid nanoparticle (LNP) technology, Engage Bio delivers therapeutic DNA alongside mRNA encoding their proprietary Tethosome protein. This protein facilitates the localization of DNA to the nucleus, enhancing gene expression by over 100-fold. Importantly, the Tethosome pl

CoverMyMeds is a healthcare technology platform dedicated to improving medication access by streamlining the prior authorization (PA) process. By automating and integrating PA workflows, CoverMyMeds connects healthcare providers, pharmacies, and health plans, reducing administrative burdens and accelerating patient access to necessary medications. The platform's extensive network includes over 950,000 providers, 50,000 pharmacies, and most health plans, representing 96% of prescription volume.

Medium Biosciences, founded in 2021 and based in Boston, Massachusetts, specializes in the development of protein therapeutics through the application of artificial intelligence (AI). By integrating advanced AI models with biological assay development, the company aims to revolutionize the biotechnology sector by creating innovative treatments for various diseases. Key Features and Functionality: - AI-Driven Protein Design: Utilizes sophisticated AI algorithms to design novel protein therapeut

CardiaTec is a pioneering TechBio company dedicated to transforming cardiovascular disease treatment through advanced computational modeling and multi-omics data analysis. By integrating genomics, epigenomics, transcriptomics, and proteomics from human cardiac tissues, CardiaTec aims to uncover novel therapeutic targets and develop first-in-class cardiovascular therapies. The company has established a proprietary multi-omics dataset, sourced from a network of 65 hospitals across the UK and US, t

Ditto Biosciences is a biotechnology company dedicated to developing innovative therapies for autoimmune diseases by harnessing the unique properties of parasite biology. By leveraging artificial intelligence and evolutionary genomics, Ditto Biosciences identifies and engineers proteins from viruses, ticks, and worms into next-generation therapeutics aimed at modulating the human immune system. Key Features and Functionality: - AI-Powered Drug Discovery: Utilizes artificial intelligence to ana

Asher Biotherapeutics is a biotechnology company pioneering a novel approach to immunotherapy through its proprietary cis-targeting platform. This innovative technology enables the selective activation of specific immune cell types, thereby enhancing therapeutic efficacy while minimizing off-target effects. By precisely engaging immune cells that drive desired responses, Asher Bio aims to overcome the limitations of conventional immunotherapies that often act indiscriminately on multiple cell ty

Evozyne is a pioneering biotechnology company that leverages generative artificial intelligence (AI) to design and develop novel therapeutic proteins aimed at addressing complex immune-mediated diseases. By integrating advanced AI models with high-throughput biological experimentation, Evozyne creates proteins with enhanced precision, stability, and specificity, offering potential solutions where traditional biologics and small molecules have been insufficient. Key Features and Functionality:

Notable is a mission-driven company transforming the way cancer is treated. Notable Labs is a translationally focused drug development company that uses a clinically validated, automated compound sensitivity platform to identify and advance novel therapeutic candidates to dramatically reduce the cost and time of the traditional drug development process.

SoftWorks AI's Trapeze for Redaction utilizes sophisticated data redaction technology to intelligently identify and remove sensitive information from your documents. Manually removing social security numbers, credit card numbers, and other information can be time-consuming, labor-intensive, and riddled with human error. Trapeze for Redaction is designed to automate, accelerate and improve the accuracy of the redaction process for organizations with high volumes of documents containing sensitive